Towards a better characterized, broadly applicable, and safer DNA-based antibody platform

This abstract was selected by our Scientific Committee to pitch on the programme in the R2B session (PM).

This abstract is not published by request of the author.



Presenting author

Giles Vermeire, PhD Student, Laboratory for Therapeutic and Diagnostic Antibodies, KU Leuven - University of Leuven
Contact us now
Get your tickets today Strategic Partners Supporting Partners